chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Injection site pain
Clinical narrative: feeling the effects with dizziness when move around.; fever of 102; pounding headache similar to migraine; Body aches accompanied symptoms; injection site started to hurt; headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 08:30(at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, migraine, asthma and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously took cefalexin (KEFLEX) and experienced drugs allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 10:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 21:30, the patient when went to bed, injection site started to hurt and developed a headache. Patient took some pain medication but it did not alleviate and the pain got worse as the night went on. On 29Apr2021, by morning, the patient had fever of 102 (unspecified unit) and a pounding headache, which is similar to a migraine. Patient considered emergency room due to severity but was able to get it down with medication. Patient had body aches accompanied symptoms and spent the day in bed trying to alleviate symptoms. On 30Apr2021 the patient had felt the effects with dizziness when moved around. Headache started when she got up and moved around but was significantly better than previous day. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of injection site hurt and headache and included treatment with pain medication (unspecified) but it did not alleviate the pain. Headache was able to get down with medication. Patient took ibuprofen (MOTRIN) for fever which helped to broke it the next day. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site hurt, headache, fever, pounding headache, body aches with symptoms and dizziness were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site swelling, Injection site warmth, Pain, Pyrexia, Sleep disorder
Clinical narrative: feeling the effects with dizziness when move around.; fever of 102; pounding headache similar to migraine; Body aches accompanied symptoms; injection site started to hurt; headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 08:30(at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, migraine, asthma and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously took cefalexin (KEFLEX) and experienced drugs allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 10:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 21:30, the patient when went to bed, injection site started to hurt and developed a headache. Patient took some pain medication but it did not alleviate and the pain got worse as the night went on. On 29Apr2021, by morning, the patient had fever of 102 (unspecified unit) and a pounding headache, which is similar to a migraine. Patient considered emergency room due to severity but was able to get it down with medication. Patient had body aches accompanied symptoms and spent the day in bed trying to alleviate symptoms. On 30Apr2021 the patient had felt the effects with dizziness when moved around. Headache started when she got up and moved around but was significantly better than previous day. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of injection site hurt and headache and included treatment with pain medication (unspecified) but it did not alleviate the pain. Headache was able to get down with medication. Patient took ibuprofen (MOTRIN) for fever which helped to broke it the next day. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site hurt, headache, fever, pounding headache, body aches with symptoms and dizziness were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: feeling the effects with dizziness when move around.; fever of 102; pounding headache similar to migraine; Body aches accompanied symptoms; injection site started to hurt; headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 08:30(at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, migraine, asthma and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously took cefalexin (KEFLEX) and experienced drugs allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 10:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 21:30, the patient when went to bed, injection site started to hurt and developed a headache. Patient took some pain medication but it did not alleviate and the pain got worse as the night went on. On 29Apr2021, by morning, the patient had fever of 102 (unspecified unit) and a pounding headache, which is similar to a migraine. Patient considered emergency room due to severity but was able to get it down with medication. Patient had body aches accompanied symptoms and spent the day in bed trying to alleviate symptoms. On 30Apr2021 the patient had felt the effects with dizziness when moved around. Headache started when she got up and moved around but was significantly better than previous day. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of injection site hurt and headache and included treatment with pain medication (unspecified) but it did not alleviate the pain. Headache was able to get down with medication. Patient took ibuprofen (MOTRIN) for fever which helped to broke it the next day. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site hurt, headache, fever, pounding headache, body aches with symptoms and dizziness were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Dizziness, Headache, Pain, Pyrexia
Clinical narrative: feeling the effects with dizziness when move around.; fever of 102; pounding headache similar to migraine; Body aches accompanied symptoms; injection site started to hurt; headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 08:30(at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, migraine, asthma and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously took cefalexin (KEFLEX) and experienced drugs allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 10:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 21:30, the patient when went to bed, injection site started to hurt and developed a headache. Patient took some pain medication but it did not alleviate and the pain got worse as the night went on. On 29Apr2021, by morning, the patient had fever of 102 (unspecified unit) and a pounding headache, which is similar to a migraine. Patient considered emergency room due to severity but was able to get it down with medication. Patient had body aches accompanied symptoms and spent the day in bed trying to alleviate symptoms. On 30Apr2021 the patient had felt the effects with dizziness when moved around. Headache started when she got up and moved around but was significantly better than previous day. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of injection site hurt and headache and included treatment with pain medication (unspecified) but it did not alleviate the pain. Headache was able to get down with medication. Patient took ibuprofen (MOTRIN) for fever which helped to broke it the next day. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site hurt, headache, fever, pounding headache, body aches with symptoms and dizziness were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: feeling the effects with dizziness when move around.; fever of 102; pounding headache similar to migraine; Body aches accompanied symptoms; injection site started to hurt; headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Apr2021 at 08:30(at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia, migraine, asthma and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously took cefalexin (KEFLEX) and experienced drugs allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 10:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 21:30, the patient when went to bed, injection site started to hurt and developed a headache. Patient took some pain medication but it did not alleviate and the pain got worse as the night went on. On 29Apr2021, by morning, the patient had fever of 102 (unspecified unit) and a pounding headache, which is similar to a migraine. Patient considered emergency room due to severity but was able to get it down with medication. Patient had body aches accompanied symptoms and spent the day in bed trying to alleviate symptoms. On 30Apr2021 the patient had felt the effects with dizziness when moved around. Headache started when she got up and moved around but was significantly better than previous day. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of injection site hurt and headache and included treatment with pain medication (unspecified) but it did not alleviate the pain. Headache was able to get down with medication. Patient took ibuprofen (MOTRIN) for fever which helped to broke it the next day. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site hurt, headache, fever, pounding headache, body aches with symptoms and dizziness were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing on day 6 has intensified; Ringing in ears; Fever of 99; "Nausa"; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: ER8736) via an unspecified route of administration in the left arm on 28Apr2021 at 13:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included "thyroid meds". Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified thyroid meds (medications) low dose. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: Unknown) via an unspecified route of administration in the left arm on 04Apr2021 at 15:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 29Apr2021, a day after the shot the patient had a fever of 99 (unspecified units) and some "nausa". The patient reported that she took a nap. On 30Apr2021, 3 days after the vaccine she experienced ringing in ears, she really noticed it only then. The patient had no other symptoms. On 03May2021, the sixth day (at the time of reporting), she reported that the ringing in ears was worse and it had intensified. The patient was super frustrated and wanted some help as she was concerned due to it. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of ringing in ears, fever of 99 (unspecified units) and "nausa" was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Body temperature, Nausea, Pyrexia, Tinnitus
Clinical narrative: Ringing on day 6 has intensified; Ringing in ears; Fever of 99; "Nausa"; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: ER8736) via an unspecified route of administration in the left arm on 28Apr2021 at 13:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included "thyroid meds". Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified thyroid meds (medications) low dose. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: Unknown) via an unspecified route of administration in the left arm on 04Apr2021 at 15:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 29Apr2021, a day after the shot the patient had a fever of 99 (unspecified units) and some "nausa". The patient reported that she took a nap. On 30Apr2021, 3 days after the vaccine she experienced ringing in ears, she really noticed it only then. The patient had no other symptoms. On 03May2021, the sixth day (at the time of reporting), she reported that the ringing in ears was worse and it had intensified. The patient was super frustrated and wanted some help as she was concerned due to it. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of ringing in ears, fever of 99 (unspecified units) and "nausa" was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Dysstasia, Gait inability, Monoplegia
Clinical narrative: Severe pain n hips . Numb leg and foot and within couple days both legs and feet numb . Lost ability to stand or walk .
Age: 27.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Dysstasia, Gait inability, Hypoaesthesia, Laboratory test
Clinical narrative: Severe pain n hips . Numb leg and foot and within couple days both legs and feet numb . Lost ability to stand or walk .
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure increased, Blood pressure measurement
Clinical narrative: High blood pressure; This is a spontaneous report from a contactable consumer (patient). A 56-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6199), via an unspecified route of administration in left arm on 05Mar2021 17:00 (at the age of 56-years-old) as dose 1, single for COVID-19 immunization. Medical history included ongoing heartburn and ongoing cholesterol. Concomitant medications included omeprazole magnesium (PRILOSEC) daily taken orally for Heart burn and ongoing; atorvastatin 10 mg daily taken orally for cholesterol and ongoing. Prior to vaccination, the patient did not receive any vaccines within four weeks. The patient experienced high blood pressure on 15Mar2021. The event resulted in Physician office visit. The patient does not have any major health issues. He has never had high blood pressure, and he have monitored his blood pressure on a relatively regular basis with a home Omron monitor. Before taking the vaccine, his blood pressure was regularly in the range of 120/80. Often, his blood pressure was even lower than this normal reading.  However, for the first time, and shortly after getting vaccinated with the BNT162B2, his blood pressure went up significantly. Patient first noticed this when he checked his blood pressure with Omron machine around 15Mar2021, and he was startled by the reading, which he recalls was 160/90. Patient took his reading several additional times, and it remained high in this range. Patient contacted his doctor, and he went to his office, and his reading at his office was 170/90. Doctor asked if patient had changed anything recently, and he had not, other than taking the vaccine. Patient's exercise routine (approximately 75 miles a week biking) and his diet (which he was mindful to watch fat content) had remained the same. When patient advised that he had received the vaccine, and in fact, got his second shot on the day of his appointment, doctor stated that it was probably a reaction to the vaccine, as he had seen several people who had strange reactions after getting the vaccine. He wanted to monitor things, so they agreed that patient would return in one month. The patient returned in one month, and his blood pressure was lower than before, but still high, reading 135/80. He asked patient to continue to monitor blood pressure. Patient have done so, and his blood pressure has continued to be high, sometimes reading in the range of 160/90, and other times reading more in the range of 135/90. However, it has remained consistently higher than he has ever had in his life since taking the vaccine. Patient asked to let him know if there is any further information that he can provide. Patient have read about other individuals who experienced spikes in their blood pressure after the vaccine in a study that he read about. No treatment was received for the event. Outcome of event was not resolved.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Hypertension
Clinical narrative: High blood pressure; This is a spontaneous report from a contactable consumer (patient). A 56-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6199), via an unspecified route of administration in left arm on 05Mar2021 17:00 (at the age of 56-years-old) as dose 1, single for COVID-19 immunization. Medical history included ongoing heartburn and ongoing cholesterol. Concomitant medications included omeprazole magnesium (PRILOSEC) daily taken orally for Heart burn and ongoing; atorvastatin 10 mg daily taken orally for cholesterol and ongoing. Prior to vaccination, the patient did not receive any vaccines within four weeks. The patient experienced high blood pressure on 15Mar2021. The event resulted in Physician office visit. The patient does not have any major health issues. He has never had high blood pressure, and he have monitored his blood pressure on a relatively regular basis with a home Omron monitor. Before taking the vaccine, his blood pressure was regularly in the range of 120/80. Often, his blood pressure was even lower than this normal reading.  However, for the first time, and shortly after getting vaccinated with the BNT162B2, his blood pressure went up significantly. Patient first noticed this when he checked his blood pressure with Omron machine around 15Mar2021, and he was startled by the reading, which he recalls was 160/90. Patient took his reading several additional times, and it remained high in this range. Patient contacted his doctor, and he went to his office, and his reading at his office was 170/90. Doctor asked if patient had changed anything recently, and he had not, other than taking the vaccine. Patient's exercise routine (approximately 75 miles a week biking) and his diet (which he was mindful to watch fat content) had remained the same. When patient advised that he had received the vaccine, and in fact, got his second shot on the day of his appointment, doctor stated that it was probably a reaction to the vaccine, as he had seen several people who had strange reactions after getting the vaccine. He wanted to monitor things, so they agreed that patient would return in one month. The patient returned in one month, and his blood pressure was lower than before, but still high, reading 135/80. He asked patient to continue to monitor blood pressure. Patient have done so, and his blood pressure has continued to be high, sometimes reading in the range of 160/90, and other times reading more in the range of 135/90. However, it has remained consistently higher than he has ever had in his life since taking the vaccine. Patient asked to let him know if there is any further information that he can provide. Patient have read about other individuals who experienced spikes in their blood pressure after the vaccine in a study that he read about. No treatment was received for the event. Outcome of event was not resolved.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure increased, Blood test
Clinical narrative: High blood pressure; This is a spontaneous report from a contactable consumer (patient). A 56-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6199), via an unspecified route of administration in left arm on 05Mar2021 17:00 (at the age of 56-years-old) as dose 1, single for COVID-19 immunization. Medical history included ongoing heartburn and ongoing cholesterol. Concomitant medications included omeprazole magnesium (PRILOSEC) daily taken orally for Heart burn and ongoing; atorvastatin 10 mg daily taken orally for cholesterol and ongoing. Prior to vaccination, the patient did not receive any vaccines within four weeks. The patient experienced high blood pressure on 15Mar2021. The event resulted in Physician office visit. The patient does not have any major health issues. He has never had high blood pressure, and he have monitored his blood pressure on a relatively regular basis with a home Omron monitor. Before taking the vaccine, his blood pressure was regularly in the range of 120/80. Often, his blood pressure was even lower than this normal reading.  However, for the first time, and shortly after getting vaccinated with the BNT162B2, his blood pressure went up significantly. Patient first noticed this when he checked his blood pressure with Omron machine around 15Mar2021, and he was startled by the reading, which he recalls was 160/90. Patient took his reading several additional times, and it remained high in this range. Patient contacted his doctor, and he went to his office, and his reading at his office was 170/90. Doctor asked if patient had changed anything recently, and he had not, other than taking the vaccine. Patient's exercise routine (approximately 75 miles a week biking) and his diet (which he was mindful to watch fat content) had remained the same. When patient advised that he had received the vaccine, and in fact, got his second shot on the day of his appointment, doctor stated that it was probably a reaction to the vaccine, as he had seen several people who had strange reactions after getting the vaccine. He wanted to monitor things, so they agreed that patient would return in one month. The patient returned in one month, and his blood pressure was lower than before, but still high, reading 135/80. He asked patient to continue to monitor blood pressure. Patient have done so, and his blood pressure has continued to be high, sometimes reading in the range of 160/90, and other times reading more in the range of 135/90. However, it has remained consistently higher than he has ever had in his life since taking the vaccine. Patient asked to let him know if there is any further information that he can provide. Patient have read about other individuals who experienced spikes in their blood pressure after the vaccine in a study that he read about. No treatment was received for the event. Outcome of event was not resolved.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Breakthrough Covid infection
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Breakthrough Covid infection
Age: 93.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count, Infection, Metabolic function test, SARS-CoV-2 test
Clinical narrative: Breakthrough Covid Disease, Nausea, Vomiting and Diarrhea
Age: 93.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Diarrhoea, Nausea, Vaccine breakthrough infection, Vomiting
Clinical narrative: Breakthrough Covid Disease, Nausea, Vomiting and Diarrhea
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough infection, Acute respiratory failure, pneumonia. bradycaria
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Bradycardia, Infection, Pneumonia
Clinical narrative: Breakthrough infection, Acute respiratory failure, pneumonia. bradycaria
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Infection, Respiratory disorder, SARS-CoV-2 test positive
Clinical narrative: Breakthrough Covid infection, acute respiratory failure
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Infection
Clinical narrative: Breakthrough Covid infection, acute respiratory failure
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Blood test, Computed tomographic gastrography, Computerised tomogram head, Head injury, Loss of consciousness
Clinical narrative: accrue pancreatitis; This is a spontaneous report from a contactable consumer reporting for him/her self. A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced accrue pancreatitis and was hospitalized on an unspecified date with outcome of unknown.  Information about lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Pain, Pancreatitis, Swelling
Clinical narrative: accrue pancreatitis; This is a spontaneous report from a contactable consumer reporting for him/her self. A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced accrue pancreatitis and was hospitalized on an unspecified date with outcome of unknown.  Information about lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Pancreatitis
Clinical narrative: accrue pancreatitis; This is a spontaneous report from a contactable consumer reporting for him/her self. A patient of unspecified age and gender received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced accrue pancreatitis and was hospitalized on an unspecified date with outcome of unknown.  Information about lot/batch number has been requested.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary pain, Back pain, Blood pressure increased, Chest X-ray, Chest discomfort
Clinical narrative: Acute extremely high blood pressure 207/118; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe headache; diarrhea; diarrhea and low grade temp (100); Feeling of "being on fire" in chest and back; Unable to move arm; Hives on face; This is a spontaneous report from a contactable consumer (patient). A 24-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FC3180, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 10Aug2021 16:30 (at the age of 24-year-old) as single dose for COVID-19 immunization. The patient medical history included Sensitivity to Penicillin, Allergy: nuts, Allergy: Carrots, Allergy: Gluten, and Allergy: Soy. There were no concomitant medications. The patient previously took Zithromax. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FA7484, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 20Jul2021 at 04:30 PM (at the age of 24-year-old) for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. The patient received no medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19, prior to vaccination. The patient had not been tested for COVID-19, since the vaccination. On 11Aug2021, the patient experienced acute extremely high blood pressure 207/118 (at hospital), severe pain in arm, armpit, chest, back, shoulder, severe headache, diarrhea and low grade temp (100), feeling of "being on fire" in chest and back, unable to move arm, hives on face. Tylenol provided zero pain relief. The patient visited the emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: 207/118 and body temperature: 100 (low grade temp) on 11Aug2021. The patient underwent unspecified labs and multiple scans (result unknown) on an unknown date in Aug2021. The patient received IV pain meds and other meds as treatment for the events. The device date was reported as 15Aug2021. The outcome of the events was reported as not resolved.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Diarrhoea, Gaze palsy, Injected limb mobility decreased, Laboratory test
Clinical narrative: Acute extremely high blood pressure 207/118; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe headache; diarrhea; diarrhea and low grade temp (100); Feeling of "being on fire" in chest and back; Unable to move arm; Hives on face; This is a spontaneous report from a contactable consumer (patient). A 24-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FC3180, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 10Aug2021 16:30 (at the age of 24-year-old) as single dose for COVID-19 immunization. The patient medical history included Sensitivity to Penicillin, Allergy: nuts, Allergy: Carrots, Allergy: Gluten, and Allergy: Soy. There were no concomitant medications. The patient previously took Zithromax. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FA7484, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 20Jul2021 at 04:30 PM (at the age of 24-year-old) for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. The patient received no medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19, prior to vaccination. The patient had not been tested for COVID-19, since the vaccination. On 11Aug2021, the patient experienced acute extremely high blood pressure 207/118 (at hospital), severe pain in arm, armpit, chest, back, shoulder, severe headache, diarrhea and low grade temp (100), feeling of "being on fire" in chest and back, unable to move arm, hives on face. Tylenol provided zero pain relief. The patient visited the emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: 207/118 and body temperature: 100 (low grade temp) on 11Aug2021. The patient underwent unspecified labs and multiple scans (result unknown) on an unknown date in Aug2021. The patient received IV pain meds and other meds as treatment for the events. The device date was reported as 15Aug2021. The outcome of the events was reported as not resolved.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pyrexia, Ultrasound Doppler, Urticaria
Clinical narrative: Acute extremely high blood pressure 207/118; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe headache; diarrhea; diarrhea and low grade temp (100); Feeling of "being on fire" in chest and back; Unable to move arm; Hives on face; This is a spontaneous report from a contactable consumer (patient). A 24-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FC3180, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 10Aug2021 16:30 (at the age of 24-year-old) as single dose for COVID-19 immunization. The patient medical history included Sensitivity to Penicillin, Allergy: nuts, Allergy: Carrots, Allergy: Gluten, and Allergy: Soy. There were no concomitant medications. The patient previously took Zithromax. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FA7484, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 20Jul2021 at 04:30 PM (at the age of 24-year-old) for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. The patient received no medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19, prior to vaccination. The patient had not been tested for COVID-19, since the vaccination. On 11Aug2021, the patient experienced acute extremely high blood pressure 207/118 (at hospital), severe pain in arm, armpit, chest, back, shoulder, severe headache, diarrhea and low grade temp (100), feeling of "being on fire" in chest and back, unable to move arm, hives on face. Tylenol provided zero pain relief. The patient visited the emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: 207/118 and body temperature: 100 (low grade temp) on 11Aug2021. The patient underwent unspecified labs and multiple scans (result unknown) on an unknown date in Aug2021. The patient received IV pain meds and other meds as treatment for the events. The device date was reported as 15Aug2021. The outcome of the events was reported as not resolved.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Axillary pain, Back pain, Blood pressure measurement, Body temperature
Clinical narrative: Acute extremely high blood pressure 207/118; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe headache; diarrhea; diarrhea and low grade temp (100); Feeling of "being on fire" in chest and back; Unable to move arm; Hives on face; This is a spontaneous report from a contactable consumer (patient). A 24-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FC3180, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 10Aug2021 16:30 (at the age of 24-year-old) as single dose for COVID-19 immunization. The patient medical history included Sensitivity to Penicillin, Allergy: nuts, Allergy: Carrots, Allergy: Gluten, and Allergy: Soy. There were no concomitant medications. The patient previously took Zithromax. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FA7484, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 20Jul2021 at 04:30 PM (at the age of 24-year-old) for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. The patient received no medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19, prior to vaccination. The patient had not been tested for COVID-19, since the vaccination. On 11Aug2021, the patient experienced acute extremely high blood pressure 207/118 (at hospital), severe pain in arm, armpit, chest, back, shoulder, severe headache, diarrhea and low grade temp (100), feeling of "being on fire" in chest and back, unable to move arm, hives on face. Tylenol provided zero pain relief. The patient visited the emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: 207/118 and body temperature: 100 (low grade temp) on 11Aug2021. The patient underwent unspecified labs and multiple scans (result unknown) on an unknown date in Aug2021. The patient received IV pain meds and other meds as treatment for the events. The device date was reported as 15Aug2021. The outcome of the events was reported as not resolved.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Diarrhoea, Feeling hot, Headache, Hypertensive crisis
Clinical narrative: Acute extremely high blood pressure 207/118; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe headache; diarrhea; diarrhea and low grade temp (100); Feeling of "being on fire" in chest and back; Unable to move arm; Hives on face; This is a spontaneous report from a contactable consumer (patient). A 24-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FC3180, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 10Aug2021 16:30 (at the age of 24-year-old) as single dose for COVID-19 immunization. The patient medical history included Sensitivity to Penicillin, Allergy: nuts, Allergy: Carrots, Allergy: Gluten, and Allergy: Soy. There were no concomitant medications. The patient previously took Zithromax. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FA7484, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 20Jul2021 at 04:30 PM (at the age of 24-year-old) for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. The patient received no medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19, prior to vaccination. The patient had not been tested for COVID-19, since the vaccination. On 11Aug2021, the patient experienced acute extremely high blood pressure 207/118 (at hospital), severe pain in arm, armpit, chest, back, shoulder, severe headache, diarrhea and low grade temp (100), feeling of "being on fire" in chest and back, unable to move arm, hives on face. Tylenol provided zero pain relief. The patient visited the emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: 207/118 and body temperature: 100 (low grade temp) on 11Aug2021. The patient underwent unspecified labs and multiple scans (result unknown) on an unknown date in Aug2021. The patient received IV pain meds and other meds as treatment for the events. The device date was reported as 15Aug2021. The outcome of the events was reported as not resolved.
Age: 24.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Mobility decreased, Pain in extremity, Pyrexia, Scan
Clinical narrative: Acute extremely high blood pressure 207/118; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe pain in arm, armpit, chest, back, shoulder; Severe headache; diarrhea; diarrhea and low grade temp (100); Feeling of "being on fire" in chest and back; Unable to move arm; Hives on face; This is a spontaneous report from a contactable consumer (patient). A 24-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FC3180, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 10Aug2021 16:30 (at the age of 24-year-old) as single dose for COVID-19 immunization. The patient medical history included Sensitivity to Penicillin, Allergy: nuts, Allergy: Carrots, Allergy: Gluten, and Allergy: Soy. There were no concomitant medications. The patient previously took Zithromax. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: FA7484, and Expiration date: Unknown), via an unspecified route of administration, administered in right arm on 20Jul2021 at 04:30 PM (at the age of 24-year-old) for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. The patient received no medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19, prior to vaccination. The patient had not been tested for COVID-19, since the vaccination. On 11Aug2021, the patient experienced acute extremely high blood pressure 207/118 (at hospital), severe pain in arm, armpit, chest, back, shoulder, severe headache, diarrhea and low grade temp (100), feeling of "being on fire" in chest and back, unable to move arm, hives on face. Tylenol provided zero pain relief. The patient visited the emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: 207/118 and body temperature: 100 (low grade temp) on 11Aug2021. The patient underwent unspecified labs and multiple scans (result unknown) on an unknown date in Aug2021. The patient received IV pain meds and other meds as treatment for the events. The device date was reported as 15Aug2021. The outcome of the events was reported as not resolved.